KR900013955A - 알러젠-유도된 비강반응중치료를 위한 흡인 루프 이뇨제의 용도 - Google Patents

알러젠-유도된 비강반응중치료를 위한 흡인 루프 이뇨제의 용도 Download PDF

Info

Publication number
KR900013955A
KR900013955A KR1019900002905A KR900002905A KR900013955A KR 900013955 A KR900013955 A KR 900013955A KR 1019900002905 A KR1019900002905 A KR 1019900002905A KR 900002905 A KR900002905 A KR 900002905A KR 900013955 A KR900013955 A KR 900013955A
Authority
KR
South Korea
Prior art keywords
diuretics
aspirated
treatment during
reactions
induced nasal
Prior art date
Application number
KR1019900002905A
Other languages
English (en)
Inventor
비안코 세바스티아노
Original Assignee
엔겔하르트, 벡커
훽스트 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 엔겔하르트, 벡커, 훽스트 아크티엔게젤샤프트 filed Critical 엔겔하르트, 벡커
Publication of KR900013955A publication Critical patent/KR900013955A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Furan Compounds (AREA)

Abstract

내용 없음

Description

알러젠-유도된 비강반응중치료를 위한 흡인 루프 이뇨제의 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 외비강내로 루프 이뇨제 용액을 분무함을 특징으로 하여, 알러젠-유도된 비강반응증을 치료하는 방법.
  2. 유효량의 루프 이뇨제를 비강에 투여함을 특징으로 하여, 알러젠-유발된 바강반응증을 치료하는 방법.
  3. 제2항에 있어서, 유효량의루프 이뇨제 용액을 비강에 분무함을 특징으로 하는 방법.
  4. 제3항에 있어서, 푸로세미드를 분무함을 특징으로 하는 방법.
  5. 비강투여용 분무용액의 제조를 위한 루프 이뇨제의 용도.
  6. 비강투여용 분무용액의 제조를 위한 푸로세미드의 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900002905A 1989-03-08 1990-03-06 알러젠-유도된 비강반응중치료를 위한 흡인 루프 이뇨제의 용도 KR900013955A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3907414.5 1989-03-08
DE3907414A DE3907414A1 (de) 1989-03-08 1989-03-08 Die anwendung inhalierter schleifendiuretika zur behandlung von allergen-induzierten nasalen reaktionen

Publications (1)

Publication Number Publication Date
KR900013955A true KR900013955A (ko) 1990-10-22

Family

ID=6375791

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900002905A KR900013955A (ko) 1989-03-08 1990-03-06 알러젠-유도된 비강반응중치료를 위한 흡인 루프 이뇨제의 용도

Country Status (18)

Country Link
US (1) US5392767A (ko)
EP (1) EP0386700B1 (ko)
JP (1) JPH02279625A (ko)
KR (1) KR900013955A (ko)
CN (1) CN1045350A (ko)
AT (1) ATE82853T1 (ko)
AU (1) AU623502B2 (ko)
CA (1) CA2011680A1 (ko)
DD (1) DD292380A5 (ko)
DE (2) DE3907414A1 (ko)
DK (1) DK0386700T3 (ko)
ES (1) ES2052998T3 (ko)
GR (1) GR3007175T3 (ko)
HU (1) HU205852B (ko)
IE (1) IE900811L (ko)
IL (1) IL93663A (ko)
NO (1) NO901078L (ko)
ZA (1) ZA901747B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0465841A3 (en) * 1990-06-13 1992-10-14 Hoechst Aktiengesellschaft Quick acting pharmaceutical inhalation forms of diuretics
DE4023086A1 (de) * 1990-07-20 1992-01-23 Hoechst Ag Methode zur behandlung von allergischer konjunktivitis
EP0499142A3 (en) * 1991-02-09 1993-05-05 Hoechst Aktiengesellschaft Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non steroidal anti-flammatory drugs
US20030185761A1 (en) 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
WO1999016417A1 (en) 1997-10-01 1999-04-08 Flemington Pharmaceutical Corporation Buccal, polar and non-polar spray or capsule
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20030077227A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20030095927A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US7231919B2 (en) 2001-09-28 2007-06-19 Kurve Technology, Inc. Particle dispersion device for nasal delivery
US8168674B1 (en) * 2002-02-22 2012-05-01 Microdose Therapeutx, Inc. Method for treating bronchial diseases
AU2003249623A1 (en) * 2002-05-09 2003-12-12 Kurve Technology, Inc. Particle dispersion chamber for nasal nebulizer
EP1673123A2 (en) * 2003-09-05 2006-06-28 Kurve Technology, Inc. Integrated nebulizer and particle dispersing chamber for delivery of medicament
WO2005023334A2 (en) * 2003-09-05 2005-03-17 Kurve Technology, Inc. Nasal adapter for the base of the nose
WO2008028092A2 (en) 2006-08-30 2008-03-06 Kurve Technology, Inc. Aerosol generating and delivery device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3500M (fr) * 1964-06-15 1965-08-23 Fo We Forschungs Und Verwertun Nouveau médicament destiné au traitement des rhinites.
NZ209900A (en) * 1984-10-16 1989-08-29 Univ Auckland Automatic inhaler
US4886811A (en) * 1988-10-24 1989-12-12 Merrell Dow Pharmaceuticals Qunolyloxazole-2-ones useful as proteinkinase C inhibitors
JPH0720862B2 (ja) * 1989-01-27 1995-03-08 ヘキスト・アクチエンゲゼルシヤフト 吸入用喘息治療剤

Also Published As

Publication number Publication date
CN1045350A (zh) 1990-09-19
CA2011680A1 (en) 1990-09-08
EP0386700A1 (de) 1990-09-12
HU901321D0 (en) 1990-05-28
JPH02279625A (ja) 1990-11-15
AU5075090A (en) 1990-10-11
NO901078D0 (no) 1990-03-07
DE3907414A1 (de) 1990-09-13
US5392767A (en) 1995-02-28
HUT52953A (en) 1990-09-28
AU623502B2 (en) 1992-05-14
DE59000518D1 (de) 1993-01-14
ES2052998T3 (es) 1994-07-16
NO901078L (no) 1990-09-10
IE900811L (en) 1990-09-08
IL93663A (en) 1994-11-11
IL93663A0 (en) 1990-12-23
ATE82853T1 (de) 1992-12-15
DD292380A5 (de) 1991-08-01
EP0386700B1 (de) 1992-12-02
ZA901747B (en) 1990-11-28
GR3007175T3 (ko) 1993-07-30
HU205852B (en) 1992-07-28
DK0386700T3 (da) 1993-03-01

Similar Documents

Publication Publication Date Title
KR900013955A (ko) 알러젠-유도된 비강반응중치료를 위한 흡인 루프 이뇨제의 용도
ATE163849T1 (de) Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
ATE74519T1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
FR2617061B1 (fr) Pulverisateur portable de liquide, notamment pour le traitement de la vegetation
FR2707184B1 (fr) Procédé de préparation de sphérules contenant un principe actif alimentaire ou pharmaceutique.
IT9048456A0 (it) Medicamenti contenenti acidi carbossilici contenenti zolfo quali agenti attivi nonche' procedimento per la loro produzione e loro impiego per la lotta ai retrovirus.
FI903483A0 (fi) Tretinoin innehaollande stabila emulsionskraemformulationer.
KR890012659A (ko) 조산아의 뇌실내 출혈방지용 치료제
ES2032303T3 (es) Soluciones nasales.
FR2674434B1 (fr) Nouvelle composition pharmaceutique a base de taurine pour l'administration par inhalation.
KR930019224A (ko) 유산 위험 치료제
DK0465454T3 (da) Fremgangsmåde samt sprøjtehoved til forstøvning af et koncentreret flydende produkt
MA19084A1 (fr) Nouveau procede d'enrobage d'au moins un principe actif medicamenteux .
ES2133500T3 (es) Envase pulverizador para pulverizar liquido medicinal a la membrana mucosa de la garganta.
GR3005100T3 (ko)
DE3688503D1 (de) Erhoehung des ausfliessens waessriger koerperfluessigkeit.
FR2656527B1 (fr) Solution d'irrigation oculaire utilisee en therapeutique pour la protection endotheliale et la conservation de la cornee.
JPS57145006A (en) Preparation of modified inorganic powder
KR900013966A (ko) 피소스티그민 및 아레콜린의 비강내투여용 조성물
MX172733B (es) Procedimiento para el desalojamiento de colesterol de la yema del huevo
KR900012622A (ko) 피부질환치료 조성물
ES458413A1 (es) Mejoras introducidas en un procedimiento de preparacion de -una composicion de anoxicilina sodica.
HUT34127A (en) Process for producing of diurethical blood-pressure decreasing combinated medical preparates and process of granulation for assuring the absorption of the reagent by regulated speed

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid